Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Ductal and Invasive Lobular Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04021069
What this trial is testing

Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer

Who this might be right for
Breast CancerInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma
Sunnybrook Health Sciences Centre 800
Early research (Phase 1)Looking for participantsNCT07020806
What this trial is testing

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Who this might be right for
Metastatic Lobular Breast Carcinoma
University of California, Davis 30
Very early researchStudy completedNCT00301041
What this trial is testing

Radiation Therapy in Treating Women With Invasive Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Francisco 20
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Testing effectiveness (Phase 2)Study completedNCT00960336
What this trial is testing

Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
ARCAGY/ GINECO GROUP 59
Not applicableUnknownNCT00602316
What this trial is testing

Multifunctional Magnetic Resonance Imaging in Predicting Breast Lesions in Women Undergoing Mastectomy for Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 20
Not applicableStudy completedNCT01819233
What this trial is testing

Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy

Who this might be right for
Ductal Breast Carcinoma in SituInvasive Ductal Breast CarcinomaInvasive Lobular Breast Carcinoma+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 38
Large-scale testing (Phase 3)Study completedNCT00433589
What this trial is testing

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 6,600
Not applicableStudy completedNCT00859157
What this trial is testing

Pain After Tumescent Mastectomy or Standard Mastectomy in Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast CancerPainPerioperative/Postoperative Complications
University of California, Davis 74
Not applicableUnknownNCT00814567
What this trial is testing

Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 2,018
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Not applicableStudy completedNCT00599989
What this trial is testing

Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerLong-term Effects Secondary to Cancer Therapy in AdultsSkin Reactions Secondary to Radiation Therapy
Abramson Cancer Center at Penn Medicine 28
Testing effectiveness (Phase 2)Study completedNCT00256217
What this trial is testing

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Who this might be right for
DCIS
Rita Sanghvi, Mehta 42
Not applicableStudy completedNCT01961531
What this trial is testing

BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)

Who this might be right for
Breast Cancer
Brown University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909
What this trial is testing

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 200
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Not applicableStudy completedNCT00602628
What this trial is testing

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 60
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Study completedNCT03947151
What this trial is testing

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer

Who this might be right for
Invasive Ductal Breast Carcinoma
Assistance Publique - Hôpitaux de Paris 8
Not applicableStudy completedNCT00945061
What this trial is testing

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 13
Next Page